Wellstar's CCTA + Heartflow Program Impact: Improving Patient Care While Driving Financial Growth

Listen in!

If you’re looking to grow your CCTA program or start one, listen in. Learn from cardiology and radiology experts at Wellstar Health System who have built a successful CCTA program. The physicians and administrators dig into the data and economics of how they’ve improved patient outcomes, increased diagnostic yields for their cath lab, and grown profits across the system.

ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

Standard transthoracic echo imaging planes for comprehensive right heart assessment. Several key views should be included in the standard echocardiographic assessment of the right heart. Image and caption courtesy of the American Society of Echocardiography.

Standard transthoracic echo imaging planes for comprehensive right heart assessment. Several key views should be included in the standard echocardiographic assessment of the right heart. Image and caption courtesy of the American Society of Echocardiography.

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

‘A new alternative’: Tiny pacemakers for infants show early promise

Chest X ray in AP projection of a neonate with an epicardial left ventricular bipolar pacing lead connected to a pediatric implantable pulse generator (IPG) in the left upper abdominal pocket. Image and caption courtesy of the American Heart Association and Circulation: Arrhythmia and Electrophysiology.

Chest X-ray in AP projection of a neonate with an epicardial left ventricular bipolar pacing lead connected to a pediatric implantable pulse generator (IPG) in the left upper abdominal pocket. Image and caption courtesy of the American Heart Association and Circulation: Arrhythmia and Electrophysiology.

A team of pediatric specialists worked closely with representative from Medtronic to develop the new pacemakers. Overall, the tiny devices—approximately one-quarter the size of a traditional pacemaker—were found to be both safe and effective. They are still under development.